Suchergebnisse - "Moss, Joe W. E."

PubPharm (15)

1

The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation

enthalten in: The Canadian journal of cardiology | 2024

von Andrade, J. | Moss, J. | Kuniss, M. | +11

2

An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population

enthalten in: PharmacoEconomics - open | 2024

von Moss, J. | Todd, D. | Grodzicki, L. | +15

3

(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability

enthalten in: Molecular nutrition & food research | 2023

von Chan, Y. | Moss, J. | Williams, J. | +8

4

(+)‐Catechin Attenuates Multiple Atherosclerosis‐Associated Processes In Vitro, Modulates Disease‐Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability

enthalten in: Molecular Nutrition & Food Research | 2023

von Chan, Y. | Moss, J. | Williams, J. | +8

5

Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat diet

enthalten in: Food & function | 2021

von Moss, J. | Williams, J. | Al-Ahmadi, W. | +9

6

Quantifying the direct secondary health care cost of seasonal influenza in England

enthalten in: BMC public health | 2020

von Moss, J. | Davidson, C. | Mattock, R. | +3

7

Quantifying the direct secondary health care cost of seasonal influenza in England

enthalten in: BMC public health | 2020

von Moss, J. | Davidson, C. | Mattock, R. | +3

8

Quantifying the direct secondary health care cost of seasonal influenza in England

enthalten in: BMC public health | 2020

von Moss, J. | Davidson, C. | Mattock, R. | +3

9

The interleukin-33-mediated inhibition of expression of two key genes implicated in atherosclerosis in human macrophages requires MAP kinase, phosphoinositide 3-kinase and nuclear factor-κB signaling pathways

enthalten in: Scientific reports | 2019

von Buckley, M. | Williams, J. | Chan, Y. | +4

10

Nutraceuticals as therapeutic agents for atherosclerosis

enthalten in: Biochimica et biophysica acta. Molecular basis of disease | 2018

von Moss, J. | Williams, J. | Ramji, D.